Remove 2024 Remove Clinic Remove Imaging Modalities Remove Nuclear Medicine
article thumbnail

SNMMI: FAPI PET/CT predicts progressive pulmonary fibrosis better than FDG

AuntMinnie

An emerging PET/CT radiotracer may be more predictive of progressive pulmonary fibrosis in interstitial lung patients than F-18 FDG PET/CT, according to research presented June 8 at the 2024 Society of Nuclear Medicine and Molecular Imaging Annual Meeting (SNMMI).

article thumbnail

Blue Earth Diagnostics, a Bracco Company, Appoints Marco Campione as Chief Executive Officer

Imaging Technology

The Company is a recognized leader throughout the nuclear medicine and oncology communities, having a strong reputation grounded in successful innovation, execution and dedicated service on behalf of patient health,” he added. Blue Earth Diagnostics, an indirect subsidiary of Bracco Imaging S.p.A.,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The rise of theranostics: Part 2 -- Moving into communities

AuntMinnie

They're also mindful of the multiple dedicated teams required to build a theranostics clinic properly. Hope, vice chair of clinical operations and strategy in the UCSF department of radiology, established the radioligand therapy group at the university. Theranostics is becoming a treatment option for a larger volume of cancer patients.

article thumbnail

SNMMI: PET/CT reveals connection between CVD and cognitive impairment

AuntMinnie

PET/CT reveals a connection between cardiovascular disease (CVD) and cognitive impairment, according to research presented at the recent Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting. When it affects the carotid arteries, it can lead to cognitive impairment and dementia, he explained.